In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum from the Haut-Ogooué region of Gabon

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 4, 2003, Pages 1021-1024

  Atteke, Christiane ^a,b   Me Ndong, Jérôme Mezui ^b   Aubouy, Agnès ^b   Maciejewski, Lucien ^c   Brocard, Jacques ^c   Lébibi, Jacques ^a   Deloron, Philippe ^b,d  

^a Univ des Sci Techniques de Masuku   (France)

^b Ctr Intl Recher Med Franceville   (France)

^c UNIV LILLE   (France)

^d INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

Author keywords

Chloroquine; Ferrocene; Malaria

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; FERROQUINE; ORGANOMETALLIC COMPOUND; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; CROSS RESISTANCE; DRUG ACTIVITY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; GABON; GEOMETRY; HOSPITAL DEPARTMENT; HUMAN; IC 50; IN VITRO STUDY; MALARIA FALCIPARUM; NONHUMAN; OUTPATIENT; PARASITE ISOLATION; PLASMODIUM FALCIPARUM; STRUCTURE ANALYSIS;

AMINOQUINOLINES; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; FERROUS COMPOUNDS; GABON; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; QUINOLINES;

EID: 0242684594     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg161     Document Type: Article

References (10)

1. World Health Organization. (1996). Malaria situation in 1993. Weekly Epidemiological Report 71, 17-22.
2. Biot, C., Glorian, G., Maciejewski, L. A. & Brocard, J. (1997). Synthesis and antimalarial activity in vitro and in vivo of a new ferrocene-chloroquine analogue. Journal of Medical Chemistry 40, 3715-8.
3. Domarle, O., Blampain, G., Agnaniet, H., Nzadiyabi, T., Lebibi, J., Brocard, J. et al. (1998). In vitro antimicrobial activity of a new organometallic analogue: ferrocene-chloroquine. Antimicrobial Agents and Chemotherapy 42, 540-4.
4. Pradines, B., Fusai, T., Daries, W., Laloge, V., Rogier, C., Millet, P. et al. (2001). Ferrocene-chloroquine analogues as antimalarial agents: in vitro activity of ferrochloroquine against 103 Gabonese isolates of Plasmodium falciparum. Journal of Antimicrobial Chemotherapy 48, 179-84.
5. Pradines, B., Tall, A., Rogier, C., Spiegel, A., Mosnier, J., Marrama, L. et al. (2002). In vitro activity of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs. Tropical Medicine and International Health 7, 265-70.
6. Pradines, B., Mabika Mamfoumbi, M., Parzy, D., Owono Medang, M., Lebeau, C., Mourou Mbina, J. R. et al. (1998). In vitro susceptibility of Gabonese wild isolates of Plasmodium falciparum to artemether, and comparison with chloroquine, quinine, halofantrine and amodiaquine. Parasitology 117, 541-5.
7. Biot, C., Delhaes, L., Abessolo, H., Domarle, O., Maciejewski, L. A., Mortuaire, M. et al. (1999). Novel metallocenic compounds as antimalarial agents. Study of the position of ferrocene in chloroquine. Journal of Organometallic Chemistry 589, 59-65.
8. Krogstad, D. J., Gluzman, I. Y., Kyle, D. E., Oduola, A. M. J., Martin, S. K., Milhous, W. K. et al. (1987). Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238, 1283-5.
9. Köpf-Maier, P. (1994). Complexes of metals other than platinum as antitumour agents. European Journal of Clinical Pharmacology 47, 1-16.
10. Hershko, C. & Peto, T. E. (1988). Deferoxamine inhibition of malaria is independent of the host iron status. Journal of Experimental Medicine 168, 375-87.